Double mutant DNMT3A AML: a unique subtype experiencing increased DNA damage and poor prognosis

Authors: Boertjes, Emma L., Massaar, Sanne, Zeilemaker, Annelieke, Konijnenburg, Jolinda, Rijken, Melissa, Kavelaars, François G., Grob, Tim, Versluis, Jurjen, Löwenberg, Bob, Valk, Peter J. M., Sanders, Mathijs A. ^∗

Source: In Blood Advances 25 March 2025 9(6):1344-1355

Younger unrelated donors may be preferable over HLA match in the PTCy era: a study from the ALWP of the EBMT

Authors: Sanz, Jaime, Labopin, Myriam, Choi, Goda, Kulagin, Alexander, Peccatori, Jacopo, Vydra, Jan, Reményi, Péter, Versluis, Jurjen, Rovira, Montserrat, Blaise, Didier, Labussière-Wallet, Hélène, Montoro, Juan, Sica, Simona, Meijer, Ellen, Itälä-Remes, Maija, Schaap, Nicolaas, Bulabois, Claude Eric, Piemontese, Simona, Mohty, Mohamad, Ciceri, Fabio

Source: In Blood 13 June 2024 143(24):2534-2543

Attitudes of healthcare professionals and drug regulators about progression-free survival as endpoint in the advanced cancer setting

Authors: Postmus, Douwe, Litiere, Saskia, Bogaerts, Jan, Versluis, Jurjen, Cornelissen, Jan J., Pignatti, Francesco

Source: In European Journal of Cancer January 2024 197

Oculocerebrorenal syndrome of Lowe protein controls cytoskeletal reorganisation during human platelet spreading

Authors: Bura, Ana, Matteis, Maria Antonietta, Bender, Markus, Swinkels, Maurice, Versluis, Jurjen, Jansen, A. J. Gerard, Jurak Begonja, Antonija

Source: British journal of haematology. 200(1):87-99

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100182461747.0x000001&indx=1&recIds=ETOCvdc_100182461747.0x000001

Comorbidities in transplant recipients with acute myeloid leukemia receiving low-intensity conditioning regimens: an ALWP EBMT study

Authors: Fein, Joshua A. ^∗, Shouval, Roni ^∗, Galimard, Jacques-Emmanuel, Labopin, Myriam, Socié, Gérard, Finke, Jürgen, Cornelissen, Jan J., Malladi, Ram, Itälä-Remes, Maija, Chevallier, Patrice, Orchard, Kim H., Bunjes, Donald, Aljurf, Mahmoud, Rubio, Marie Thérèse, Versluis, Jurjen, Mohty, Mohamad, Nagler, Arnon

Source: In Blood Advances 23 May 2023 7(10):2143-2152

The added value of multi‐state modelling in a randomized controlled trial: The HOVON 102 study re‐analyzed

Authors: Bakunina, Katerina, Putter, Hein, Versluis, Jurjen, Koster, Eva A. S., Holt, Bronno, Manz, Markus G., Breems, Dimitri A., Gjertsen, Bjorn T., Cloos, Jacqueline, Valk, Peter J. M., Passweg, Jakob, Pabst, Thomas, Ossenkoppele, Gert J., Löwenberg, Bob, Cornelissen, Jan J., Wreede, Liesbeth C.

Source: Cancer medicine. 11(3):630-640

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100139983215.0x000001&indx=1&recIds=ETOCvdc_100139983215.0x000001

Disease characteristics and outcomes of acute myeloid leukemia in germline RUNX1 deficiency (Familial Platelet Disorder with associated Myeloid Malignancy).

Authors: Ernst, Martijn P. T., Versluis, Jurjen, Valk, Peter J. M., Bierings, Marc, Tamminga, Rienk Y. J., Hooimeijer, Louise H., Döhner, Konstanze, Gresele, Paolo, Tawana, Kiran, Langemeijer, Saskia M. C., Van der Reijden, Bert A., Podgornik, Helena, Sever, Matjaz, Tvedt, Tor H. A., Vulliamy, Tom, Fitzgibbon, Jude, Dokal, Inderjeet, Baliakas, Panagiotis, Bastida, José M., Pohlkamp, Christian

Source: HemaSphere; Jan2025, Vol. 9 Issue 1, p1-13, 13p

The role of allogeneic stem cell transplantation in acute myeloid leukemia with translocation t(8;16)(p11;p13).

Authors: Schmälter, Ann‐Kristin, Labopin, Myriam, Versluis, Jurjen, Gallego Hernanz, Maria Pilar, Eder, Matthias, von dem Borne, Peter, Socié, Gerard, Chevallier, Patrice, Forcade, Edouard, Neubauer, Andreas, Baron, Frédéric, Bazarbachi, Ali, Bug, Gesine, Nagler, Arnon, Schmid, Christoph, Esteve, Jordi, Mohty, Mohamad, Ciceri, Fabio

Source: American Journal of Hematology; Jan2025, Vol. 100 Issue 1, p85-92, 8p

Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy

Authors: Versluis, Jurjen, Pandey, Manu, Flamand, Yael, Haydu, J. Erika, Belizaire, Roger, Faber, Mark, Vedula, Rahul S., Charles, Anne, Copson, Kevin M., Shimony, Shai, Rozental, Alon, Bendapudi, Pavan K., Wolach, Ofir, Griffiths, Elizabeth A., Thompson, James E., Stone, Richard M., DeAngelo, Daniel J., Neuberg, Donna, Luskin, Marlise R., Wang, Eunice S., Lindsley, R. Coleman ^*

Source: In Blood Advances 10 May 2022 6(9):2835-2846

Double mutant DNMT3AAML: a unique subtype experiencing increased DNA damage and poor prognosis

Authors: Boertjes, Emma L., Massaar, Sanne, Zeilemaker, Annelieke, Konijnenburg, Jolinda, Rijken, Melissa, Kavelaars, François G., Grob, Tim, Versluis, Jurjen, Löwenberg, Bob, Valk, Peter J. M., Sanders, Mathijs A.

Source: Blood Advances; March 2025, Vol. 9 Issue: 6 p1344-1355, 12p

Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood and Marrow Transplantation registry

Authors: Shouval, Roni ^{*, *}, Fein, Joshua A ^*, Labopin, Myriam, Cho, Christina, Bazarbachi, Ali, Baron, Frédéric, Bug, Gesine, Ciceri, Fabio, Corbacioglu, Selim, Galimard, Jacques-Emmanuel, Giebel, Sebastian, Gilleece, Maria H, Giralt, Sergio, Jakubowski, Ann, Montoto, Silvia, O'Reilly, Richard J, Papadopoulos, Esperanza B, Peric, Zinaida, Ruggeri, Annalisa, Sanz, Jaime, Sauter, Craig S, Savani, Bipin N, Schmid, Christoph, Spyridonidis, Alexandros, Tamari, Roni, Versluis, Jurjen, Yakoub-Agha, Ibrahim, Perales, Miguel Angel, Mohty, Mohamad, Nagler, Arnon

Source: In The Lancet Haematology March 2021 8(3):e205-e215

Pretreatment clinical and genetic factors predict early post‐treatment mortality in fit AML patients following induction

Authors: Haydu, J. Erika, Flamand, Yael, Vedula, Rahul S., Versluis, Jurjen, Charles, Anne, Copson, Kevin M., Stone, Richard M., DeAngelo, Daniel J., Neuberg, Donna, Lindsley, R. Coleman, Luskin, Marlise R.

Source: American journal of hematology. 96(7):E259-E262

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100125675247.0x000001&indx=1&recIds=ETOCvdc_100125675247.0x000001

Higher survival following transplantation with a mismatched unrelated donor with posttransplant cyclophosphamide‐based graft‐versus‐host disease prophylaxis than with double unit umbilical cord blood in patients with acute myeloid leukemia in first complete remission: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Authors: Baron, Frédéric, Labopin, Myriam, Versluis, Jurjen, Vydra, Jan, von dem Borne, Peter A., Nicholson, Emma, Blaise, Didier, Protheroe, Rachel, Kulagin, Alexander, Bulabois, Claude Eric, Rovira, Montserrat, Chevallier, Patrice, Forcade, Edouard, Byrne, Jenny, Sanz, Jaime, Ruggeri, Annalisa, Mohty, Mohamad, Ciceri, Fabio

Source: American Journal of Hematology; Dec2024, Vol. 99 Issue 12, p2296-2305, 10p

Risk Stratification in Older Intensively Treated Patients With AML.

Authors: Versluis, Jurjen, Metzner, Marlen, Wang, Ariel, Gradowska, Patrycja, Thomas, Abin, Jakobsen, Niels Asger, Kennedy, Alison, Moore, Rachel, Boertjes, Emma, Vonk, Christian M., Kavelaars, Francois G., Rijken, Melissa, Gilkes, Amanda, Schwab, Claire, Beverloo, H. Berna, Manz, Markus, Visser, Otto, Van Elssen, Catharina H.M.J., de Weerdt, Okke, Tick, Lidwine W.

Source: Journal of Clinical Oncology; 12/1/2024, Vol. 42 Issue 34, p4084-4094, 13p

Externally Controlled Studies Using Real-World Data in Patients With Hematological Cancers: A Systematic Review.

Authors: Hermans, Sjoerd J. F., van der Maas, Niek G., van Norden, Yvette, Dinmohamed, Avinash G., Berkx, Elizabeth, Huijgens, Peter C., Rivera, Donna R., de Claro, R. Angelo, Pignatti, Francesco, Versluis, Jurjen, Cornelissen, Jan J.

Source: JAMA Oncology; Oct2024, Vol. 10 Issue 10, p1426-1436, 11p

Risks and benefits in a personalized application of allogeneic transplantation in patients with AML in first CR

Authors: Versluis, Jurjen, Cornelissen, Jan J.

Source: In Seminars in Hematology April 2019 56(2):164-170

Prognostic impact of number of induction courses to attain complete remission in patients with acute myeloid leukemia transplanted with either a matched sibling or human leucocyte antigen 10/10 or 9/10 unrelated donor: An Acute Leukemia Working Party European Society for Blood and Marrow Transplantation study

Authors: Loke, Justin, Labopin, Myriam, Craddock, Charles, Socié, Gérard, Gedde‐Dahl, Tobias, Blaise, Didier, Forcade, Edouard, Salmenniemi, Urpu, Huynh, Anne, Versluis, Jurjen, Yakoub‐Agha, Ibrahim, Labussière‐Wallet, Hélène, Maertens, Johan, Passweg, Jakob, Bulabois, Claude Eric, Gabellier, Ludovic, Mielke, Stephan, Castilla‐Llorente, Cristina, Deconinck, Eric, Brissot, Eolia

Source: Cancer (0008543X); Aug2024, Vol. 130 Issue 15, p2642-2651, 10p

Subject Terms: ACUTE myeloid leukemia, ACUTE leukemia, STEM cell transplantation, LEUKOCYTES, BONE marrow

Lower relapse incidence with HAPLO versus MSD or MUD HCTs for AML patients with KMT2A rearrangement: a study from the Global Committee and the ALWP of the EBMT.

Authors: Ye, Yishan, Labopin, Myriam, Chen, Jia, Wu, Depei, Gedde-Dahl Sr., Tobias, Blaise, Didier, Socie, Gérard, Forcade, Edouard, Salmenniemi, Urpu, Maury, Sébastien, Versluis, Jurjen, Bazarbachi, Ali, Nagler, Arnon, Brissot, Eolia, Li, Lin, Luo, Yi, Shi, Jimin, Ciceri, Fabio, Huang, He, Mohty, Mohamad

Source: Blood Cancer Journal; 5/27/2024, Vol. 14 Issue 1, p1-6, 6p

Subject Terms: ACUTE myeloid leukemia, MUD, CORD blood, HEMATOPOIETIC stem cell transplantation

Benefits and risks of clofarabine in adult acute lymphoblastic leukemia investigated in depth by multi‐state modeling.

Authors: Hermans, Sjoerd J. F., van Norden, Yvette, Versluis, Jurjen, Rijneveld, Anita W., van der Holt, Bronno, de Weerdt, Okke, Biemond, Bart J., van de Loosdrecht, Arjan A., van der Wagen, Lotte E., Bellido, Mar, van Gelder, Michel, van der Velden, Walter J. F. M., Selleslag, Dominik, van Lammeren‐Venema, Daniëlle, van der Velden, Vincent H. J., de Wreede, Liesbeth C., Postmus, Douwe, Pignatti, Francesco, Cornelissen, Jan J.

Source: Cancer Medicine; May2024, Vol. 13 Issue 9, p1-11, 11p

Subject Terms: LYMPHOBLASTIC leukemia, ACUTE leukemia, ADULTS

Alternative donors for allogeneic hematopoietic stem cell transplantation in poor-risk AML in CR1

Authors: Versluis, Jurjen ¹, Labopin, Myriam ^{2, 3, 4, 5}, Ruggeri, Annalisa ^{4, 6}, Socie, Gerard ^{7, 8}, Wu, Depei ⁹, Volin, Liisa ¹⁰, Blaise, Didier ¹¹, Milpied, Noel ¹², Craddock, Charles ¹³, Yakoub-Agha, Ibrahim ¹⁴, Maertens, Johan ¹⁵, Ljungman, Per ¹⁶, Huynh, Anne ¹⁷, Michallet, Mauricette ¹⁸, Deconinck, Eric ¹⁹, Chevallier, Patrice ²⁰, Passweg, Jakob ²¹, Ciceri, Fabio ²², Mohty, Mohamad ^{2, 3, 4}, Cornelissen, Jan J. ^{1, *, ***}, Nagler, Arnon ^{5, 23, *}

Source: In Blood Advances 28 February 2017 1(7):477-485